Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 9/2019

01.09.2019 | Microvascular Complications—Retinopathy (DL Chao and G Yiu, Section Editors)

Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application

verfasst von: Valentina Bellemo, Gilbert Lim, Tyler Hyungtaek Rim, Gavin S. W. Tan, Carol Y. Cheung, SriniVas Sadda, Ming-guang He, Adnan Tufail, Mong Li Lee, Wynne Hsu, Daniel Shu Wei Ting

Erschienen in: Current Diabetes Reports | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This paper systematically reviews the recent progress in diabetic retinopathy screening. It provides an integrated overview of the current state of knowledge of emerging techniques using artificial intelligence integration in national screening programs around the world. Existing methodological approaches and research insights are evaluated. An understanding of existing gaps and future directions is created.

Recent Findings

Over the past decades, artificial intelligence has emerged into the scientific consciousness with breakthroughs that are sparking increasing interest among computer science and medical communities. Specifically, machine learning and deep learning (a subtype of machine learning) applications of artificial intelligence are spreading into areas that previously were thought to be only the purview of humans, and a number of applications in ophthalmology field have been explored. Multiple studies all around the world have demonstrated that such systems can behave on par with clinical experts with robust diagnostic performance in diabetic retinopathy diagnosis. However, only few tools have been evaluated in clinical prospective studies.

Summary

Given the rapid and impressive progress of artificial intelligence technologies, the implementation of deep learning systems into routinely practiced diabetic retinopathy screening could represent a cost-effective alternative to help reduce the incidence of preventable blindness around the world.
Literatur
1.
Leasher JL, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care. 2016;39(9):1643–9.PubMedCrossRef
2.
YauJW, RogersSL, KawasakiR, LamoureuxEL, KowalskiJW, BekT, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012:DC_111909.
3.
Cheung N, Mitchell P. Wong TY. Diabetic retinopathy. 2010;376:13.
4.
SabanayagamC, BanuR, CheeML, LeeR, WangYX, TanG, et al. Incidence and progression of diabetic retinopathy: a systematic review. Lancet Diabetes Endocrinol2018.
5.
Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–77.PubMedCrossRef
6.
Klein R, Klein BE. Screening for diabetic retinopathy, revisited. Am J Ophthalmol. 2002;134(2):261–3.PubMedCrossRef
7.
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the International Council of Ophthalmology Recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125:1608–22.PubMedCrossRef
8.
Wong TY, Cheung CMG, Larsen M, Sharma S, Simó R. Diabetic retinopathy. Nature Reviews Disease Primers. 2016;2:16012.PubMedCrossRef
9.
Huang OS, Zheng Y, Tay WT, Chiang PP-C, Lamoureux EL, Wong TY. Lack of awareness of common eye conditions in the community. Ophthalmic Epidemiol. 2013;20(1):52–60.PubMedCrossRef
10.
Yu K-H, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nature Biomedical Engineering. 2018;2(10):719–31.PubMedCrossRef
11.
Lee A, Taylor P, Kalpathy-Cramer J, Tufail A. Machine learning has arrived! Ophthalmology. 2017;124(12):1726–8.PubMedCrossRef
12.
13.
Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, et al. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24–9.PubMedCrossRef
14.
FogelAL, KvedarJC. Artificial intelligence powers digital medicine. npj Digital Medicine. 2018;1(1):5.
15.
Lakhani P, Sundaram B. Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using convolutional neural networks. Radiology. 2017;284(2):574–82.PubMedCrossRef
16.
Ting DS, Yi PH, Hui F. Clinical applicability of deep learning system in detecting tuberculosis with chest radiography. Radiology. 2018;286(2):729–31.PubMedCrossRef
17.
HwangEJ, ParkS, JinK-N, Kim JI, Choi SY, Lee JH, et al. Development and Validation of a Deep Learning-Based Automatic Detection Algorithm for Active Pulmonary Tuberculosis on Chest Radiographs. Clin Infect Dis. 2018.
18.
Titano JJ, Badgeley M, Schefflein J, Pain M, Su A, Cai M, et al. Automated deep-neural-network surveillance of cranial images for acute neurologic events. Nat Med. 2018;24(9):1337–41.PubMedCrossRef
19.
Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115–8.PubMedCrossRefPubMedCentral
20.
•• Ting DSW, Cheung CY-L, Lim G, Tan GSW, Quang ND, Gan A, et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA. 2017;318(22):2211–23. Findings from this study suggest that deep learning systems can be generalised on different patient cohorts under different settings and conditions.PubMedPubMedCentralCrossRef
21.
•• Gulshan V, Peng L, Coram M, Stumpe MC, Wu D, Narayanaswamy A, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016;316(22):2402. Findings from this study suggest that deep learning can represent a suitable tool with clinical acceptable sensitivity and specificity for detecting referable diabetic retinopathy.PubMedCrossRef
22.
Bejnordi BE, Veta M, Van Diest PJ, Van Ginneken B, Karssemeijer N, Litjens G, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA. 2017;318(22):2199–210.CrossRef
23.
Liang H, Tsui BY, Ni H, Valentim CCS, Baxter SL, Liu G, et al. Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence. Nat Med. 2019;25(3):433–8.PubMedCrossRef
24.
Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56.PubMedCrossRef
25.
Nsoesie EO. Evaluating artificial intelligence applications in clinical settings. JAMA Netw Open. 2018;1(5):e182658.PubMedCrossRef
26.
He J, Baxter SL, Xu J, Xu J, Zhou X, Zhang K. The practical implementation of artificial intelligence technologies in medicine. Nat Med. 2019;25(1):30–6.PubMedCrossRefPubMedCentral
27.
Beam AL, Kohane IS. Translating artificial intelligence into clinical care. JAMA. 2016;316(22):2368–9.PubMedCrossRef
28.
Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;319(13):1317–8.PubMedCrossRef
29.
Stead WW. Clinical implications and challenges of artificial intelligence and deep learning. JAMA. 2018;320(11):1107–8.PubMedCrossRef
30.
Ting DSW, Pasquale LR, Peng L, Campbell JP, Lee AY, Raman R, et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167–75.PubMedCrossRef
31.
Grassmann F, Mengelkamp J, Brandl C, Harsch S, Zimmermann ME, Linkohr B, et al. A deep learning algorithm for prediction of age-related eye disease study severity scale for age-related macular degeneration from color fundus photography. Ophthalmology. 2018;125(9):1410–20.PubMedCrossRef
32.
Burlina PM, Joshi N, Pekala M, Pacheco KD, Freund DE, Bressler NM. Automated grading of age-related macular degeneration from color fundus images using deep convolutional neural networks. JAMA ophthalmology. 2017;135(11):1170–6.PubMedPubMedCentralCrossRef
33.
Burlina PM, Joshi N, Pacheco KD, Freund DE, Kong J, Bressler NM. Use of deep learning for detailed severity characterization and estimation of 5-year risk among patients with age-related macular degeneration. JAMA ophthalmology. 2018;136(12):1359–66.PubMedPubMedCentralCrossRef
34.
Hood DC, De Moraes CG. Efficacy of a deep learning system for detecting glaucomatous optic neuropathy based on color fundus photographs. Ophthalmology. 2018;125(8):1207–8.PubMedCrossRef
35.
Lim G, Cheng Y, Hsu W, Lee ML, editors. Integrated optic disc and cup segmentation with deep learning. 2015 IEEE 27th International Conference on Tools with Artificial Intelligence (ICTAI); 2015: IEEE.
36.
Brown JM, Campbell JP, Beers A, Chang K, Ostmo S, Chan RVP, et al. Automated diagnosis of plus disease in retinopathy of prematurity using deep convolutional neural networks. JAMA ophthalmology. 2018;136(7):803–10.PubMedPubMedCentralCrossRef
37.
TingDSW, WuW-C, TothC. Deep learning for retinopathy of prematurity screening. Br J Ophthalmol. 2018:bjophthalmol-2018-313290.
38.
Abràmoff MD, Lou Y, Erginay A, Clarida W, Amelon R, Folk JC, et al. Improved automated detection of diabetic retinopathy on a publicly available dataset through integration of deep learning. Investigative Opthalmology & Visual Science. 2016;57(13):5200.CrossRef
39.
AbràmoffMD, LavinPT, BirchM, ShahN, FolkJC. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. npj Digital Medicine. 2018;1(1).
40.
Gargeya R, Leng T. Automated identification of diabetic retinopathy using deep learning. Ophthalmology. 2017;124(7):962–9.PubMedCrossRef
41.
Lee CS, Baughman DM, Lee AY. Deep learning is effective for classifying Normal versus age-related macular degeneration OCT images. Ophthalmology Retina. 2017;1(4):322–7.PubMedPubMedCentralCrossRef
42.
Treder M, Lauermann JL, Eter N. Automated detection of exudative age-related macular degeneration in spectral domain optical coherence tomography using deep learning. Graefes Arch Clin Exp Ophthalmol. 2018;256(2):259–65.PubMedCrossRef
43.
Kermany DS, Goldbaum M, Cai W, Valentim CCS, Liang H, Baxter SL, et al. Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning. Cell. 2018;172(5):1122–31.e9.PubMedCrossRef
44.
Kihara Y, Heeren TF, Lee CS, Wu Y, Xiao S, Tzaridis S, et al. Estimating Retinal Sensitivity Using Optical Coherence Tomography With Deep-Learning Algorithms in Macular Telangiectasia Type 2. JAMA Netw Open. 2019;2(2):e188029–e.PubMedPubMedCentralCrossRef
45.
Schmidt-Erfurth U, Bogunovic H, Sadeghipour A, Schlegl T, Langs G, Gerendas BS, et al. Machine learning to analyze the prognostic value of current imaging biomarkers in Neovascular age-related macular degeneration. Ophthalmology Retina. 2018;2(1):24–30.PubMedCrossRef
46.
LeeCS, TyringAJ, DeruyterNP, WuY, RokemA, LeeAY. Deep-Learning Based, Automated Segmentation Of Macular Edema In Optical Coherence Tomography. bioRxiv. 2017:135640.
47.
Schlegl T, Waldstein SM, Bogunovic H, Endstraßer F, Sadeghipour A, Philip A-M, et al. Fully automated detection and quantification of macular fluid in OCT using deep learning. Ophthalmology. 2018;125(4):549–58.PubMedCrossRef
48.
• De Fauw J, Ledsam JR, Romera-Paredes B, Nikolov S, Tomasev N, Blackwell S, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med. 2018;24(9):1342–50. Findings from this study suggest that deep learning in making referral recommendations can reach or exceed that of human experts on a range of sight-threatening retinal diseases.PubMedCrossRef
49.
Varadarajan AV, Poplin R, Blumer K, Angermueller C, Ledsam J, Chopra R, et al. Deep learning for predicting refractive error from retinal fundus images. Invest Ophthalmol Vis Sci. 2018;59(7):2861–8.PubMedCrossRef
50.
Xiao S, Rokem A, Lee CS, Wilson L, Pepple K, Sabesan R, et al. Fully automated quantification of retinal cones and anterior chamber cells using deep learning. Invest Ophthalmol Vis Sci. 2018;59(9):1222.
51.
Wen JC, Lee CS, Keane PA, Xiao S, Wu Y, Rokem A, et al. Forecasting Future Humphrey Visual Fields Using Deep Learning. arXiv preprint arXiv:180404543. 2018.
52.
Poplin R, Varadarajan AV, Blumer K, Liu Y, McConnell MV, Corrado GS, et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nature Biomedical Engineering. 2018;2(3):158–64.PubMedCrossRef
53.
Ting DSW, Wong TY. Eyeing cardiovascular risk factors. Nature Biomedical Engineering. 2018;2(3):140–1.PubMedCrossRef
54.
TingDS, CheungCY, NguyenQ, SabanayagamC, LimG, LimZW, et al. Deep learning in estimating prevalence and systemic risk factors for diabetic retinopathy: a multi-ethnic study. npj Digital Medicine. 2019;2(1):24.
55.
Wong TY, Bressler NM. Artificial intelligence with deep learning technology looks into diabetic retinopathy screening. JAMA. 2016;316(22):2366–7.PubMedCrossRef
56.
Niemeijer M, Abramoff MD, van Ginneken B. Image structure clustering for image quality verification of color retina images in diabetic retinopathy screening. Med Image Anal. 2006;10(6):888–98.PubMedCrossRef
57.
Niemeijer M, Staal J, van Ginneken B, Loog M, Abramoff MD, editors. Comparative study of retinal vessel segmentation methods on a new publicly available database. Medical imaging 2004: image processing; 2004: International Society for Optics and Photonics.
58.
Staal J, Abràmoff MD, Niemeijer M, Viergever MA, Van Ginneken B. Ridge-based vessel segmentation in color images of the retina. IEEE Trans Med Imaging. 2004;23(4):501–9.PubMedCrossRef
59.
AbramoffMD, NiemeijerM, editors. The automatic detection of the optic disc location in retinal images using optic disc location regression. 2006 International Conference of the IEEE Engineering in Medicine and Biology Society; 2006: IEEE.
60.
Niemeijer M, Van Ginneken B, Staal J, Suttorp-Schulten MS, Abràmoff MD. Automatic detection of red lesions in digital color fundus photographs. IEEE Trans Med Imaging. 2005;24(5):584–92.PubMedCrossRef
61.
Niemeijer M, van Ginneken B, Russell SR, Suttorp-Schulten MS, Abramoff MD. Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color fundus photographs for diabetic retinopathy diagnosis. Invest Ophthalmol Vis Sci. 2007;48(5):2260–7.PubMedCrossRef
62.
Abràmoff MD, Niemeijer M, Suttorp-Schulten MS, Viergever MA, Russell SR, Van Ginneken B. Evaluation of a system for automatic detection of diabetic retinopathy from color fundus photographs in a large population of patients with diabetes. Diabetes Care. 2008;31(2):193–8.PubMedCrossRef
63.
Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–82.PubMedCrossRef
64.
Group ETDRSR. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology. 1991;98(5):823–33.CrossRef
65.
Krause J, Gulshan V, Rahimy E, Karth P, Widner K, Corrado GS, et al. Grader variability and the importance of reference standards for evaluating machine learning models for diabetic retinopathy. Ophthalmology. 2018;125(8):1264–72.PubMedCrossRef
66.
Nguyen HV, Tan GSW, Tapp RJ, Mital S, Ting DSW, Wong HT, et al. Cost-effectiveness of a national telemedicine diabetic retinopathy screening program in Singapore. Ophthalmology. 2016;123(12):2571–80.PubMedCrossRef
67.
Peto T, Tadros C. Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom. Current diabetes reports. 2012;12(4):338–45.PubMedCrossRef
68.
SayresR, TalyA, RahimyE, BlumerK, CozD, Hammel N, et al. Using a Deep Learning Algorithm and Integrated Gradients Explanation to Assist Grading for Diabetic Retinopathy. Ophthalmology. 2018.
69.
Scotland GS, McNamee P, Philip S, Fleming AD, Goatman KA, Prescott GJ, et al. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland. Br J Ophthalmol. 2007;91(11):1518–23.PubMedPubMedCentralCrossRef
70.
Scotland GS, McNamee P, Fleming AD, Goatman KA, Philip S, Prescott GJ, et al. Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy. Br J Ophthalmol. 2010;94(6):712–9.PubMedCrossRef
71.
Philip S, Fleming AD, Goatman KA, Fonseca S, Mcnamee P, Scotland GS, et al. The efficacy of automated “disease/no disease” grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol. 2007;91(11):1512–7.PubMedPubMedCentralCrossRef
72.
Kapetanakis VV, Rudnicka AR, Liew G, Owen CG, Lee A, Louw V, et al. A study of whether automated diabetic retinopathy image assessment could replace manual grading steps in the English national screening Programme. J Med Screen. 2015;22(3):112–8.PubMedCrossRef
73.
Tufail A, Rudisill C, Egan C, Kapetanakis VV, Salas-Vega S, Owen CG, et al. Automated diabetic retinopathy image assessment software: diagnostic accuracy and cost-effectiveness compared with human graders. Ophthalmology. 2017;124(3):343–51.PubMedCrossRef
74.
Raman R, Ganesan S, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care. 2014;2(1):e000005.PubMedPubMedCentralCrossRef
75.
Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai urban rural epidemiology study (CURES) eye study. I Invest Ophthalmol Vis Sci. 2005;46(7):2328–33.PubMedCrossRef
76.
Rajalakshmi R, Arulmalar S, Usha M, Prathiba V, Kareemuddin KS, Anjana RM, et al. Validation of smartphone based retinal photography for diabetic retinopathy screening. PLoS One. 2015;10(9):e0138285e.CrossRef
77.
Rajalakshmi R, Subashini R, Anjana RM, Mohan V. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence. Eye. 2018;32(6):1138–44.PubMedPubMedCentralCrossRef
78.
SundararajanM, TalyA, YanQ, editors. Axiomatic attribution for deep networks. Proceedings of the 34th International Conference on Machine Learning-Volume 70; 2017: JMLR. org.
79.
Raumviboonsuk P, Krause J, Chotcomwongse P, Sayres R, Raman R, Widner K, et al. Deep Learning vs. Human Graders for Classifying Severity Levels of Diabetic Retinopathy in a Real-World Nationwide Screening Program. arXiv preprint arXiv:181008290. 2018.
80.
Bach S, Binder A, Montavon G, Klauschen F, Müller K-R, Samek W. On pixel-wise explanations for non-linear classifier decisions by layer-wise relevance propagation. PLoS One. 2015;10(7):e0130140.PubMedPubMedCentralCrossRef
81.
82.
Simonyan K, Vedaldi A, Zisserman A. Deep inside convolutional networks: Visualising image classification models and saliency maps. arXiv preprint arXiv:13126034. 2013.
83.
Shrikumar A, Greenside P, Shcherbina A, Kundaje A. Not just a black box: Learning important features through propagating activation differences. arXiv preprint arXiv:160501713. 2016.
84.
Keel S, Wu J, Lee PY, Scheetz J, He M. Visualizing deep learning models for the detection of referable diabetic retinopathy and Glaucoma. JAMA ophthalmology. 2019;137(3):288–92.PubMedCrossRef
85.
KeelS, LeePY, ScheetzJ, LiZ, KotowiczMA, MacIsaacRJ, et al. Feasibility and patient acceptability of a novel artificial intelligence-based screening model for diabetic retinopathy at endocrinology outpatient services: a pilot study. Sci Rep. 2018;8(1).
86.
Kanagasingam Y, Xiao D, Vignarajan J, Preetham A, Tay-Kearney M-L, Mehrotra A. Evaluation of artificial intelligence–based grading of diabetic retinopathy in primary care. JAMA Netw Open. 2018;1(5):e182665.PubMedPubMedCentralCrossRef
87.
Hansen MB, Abràmoff MD, Folk JC, Mathenge W, Bastawrous A, Peto T. Results of automated retinal image analysis for detection of diabetic retinopathy from the Nakuru study, Kenya. PloS one. 2015;10(10):e0139148.PubMedPubMedCentralCrossRef
88.
Abràmoff MD, Reinhardt JM, Russell SR, Folk JC, Mahajan VB, Niemeijer M, et al. Automated early detection of diabetic retinopathy. Ophthalmology. 2010;117(6):1147–54.PubMedCrossRef
89.
Bellemo V, Lim ZW, Lim G, Nguyen QD, Xie Y, Yip MYT, et al. Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study. The Lancet Digital Health. 2019;1(1):e35–44.CrossRefPubMed
90.
Naylor CD. On the prospects for a (deep) learning health care system. JAMA. 2018;320(11):1099–100.PubMedCrossRef
91.
Shortliffe EH, Davis R, Axline SG, Buchanan BG, Green CC, Cohen SN. Computer-based consultations in clinical therapeutics: explanation and rule acquisition capabilities of the MYCIN system. Comput Biomed Res. 1975;8(4):303–20.PubMedCrossRef
92.
Miller RA, Pople HE Jr, Myers JD. Internist-I, an experimental computer-based diagnostic consultant for general internal medicine. N Engl J Med. 1982;307(8):468–76.PubMedCrossRef
93.
Yu VL, Fagan LM, Wraith SM, Clancey WJ, Scott AC, Hannigan J, et al. Antimicrobial selection by a computer: ablinded evaluation by infectious diseases experts. JAMA. 1979;242(12):1279–82.PubMedCrossRef
94.
Shortliffe EH, Sepúlveda MJ. Clinical decision support in the era of artificial IntelligenceClinical decision support in the era of artificial intelligence. JAMA. 2018;320(21):2199–200.PubMedCrossRef
95.
Caruana R, Lou Y, Gehrke J, Koch P, Sturm M, Elhadad N, editors. Intelligible models for healthcare: Predicting pneumonia risk and hospital 30-day readmission. Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; 2015: ACM.
96.
Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D, editors. Grad-cam: Visual explanations from deep networks via gradient-based localization. Proceedings of the IEEE International Conference on Computer Vision; 2017.
97.
Burlina PM, Joshi N, Pacheco KD, Liu TYA, Bressler NM. Assessment of deep generative models for high-resolution synthetic retinal image generation of age-related macular degeneration. JAMA ophthalmology. 2019;137(3):258–64.PubMedCrossRefPubMedCentral
98.
Shrikumar A, Greenside P, Kundaje A, editors. Learning important features through propagating activation differences. Proceedings of the 34th International Conference on Machine Learning-Volume 70; 2017: JMLR. org.
99.
100.
Sullivan HR, Schweikart SJ. Are current tort liability doctrines adequate for addressing injury caused by AI? AMA J Ethics. 2019;21(2):160–6.CrossRef
101.
Goh JKH, Cheung CY, Sim SS, Tan PC, Tan GSW, Wong TY. Retinal imaging techniques for diabetic retinopathy screening. J Diabetes Sci Technol. 2016;10(2):282–94.PubMedPubMedCentralCrossRef
102.
Liew CJ, Krishnaswamy P, Cheng L, Tan CH, Poh A, Lim T. Artificial intelligence and radiology in Singapore: championing a new age of augmented imaging for unsurpassed patient care. Ann Acad Med Singap. 2019;48:16–24.PubMed
103.
LimG, LeeML, HsuW. Intermediate goals in deep learning for retinal image analysis. ACCV Workshop on AI for Retinal Image Analysis, ACCV2018, 2019.
104.
LimG, LimZW, DejiangX, TingDSW, WongTY, LeeML, et al.Feature isolation for hypothesis testing in retinal imaging: an ischemic stroke prediction case study. Innovative Applications of Artificial Intelligence 2019.
Metadaten
Titel
Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application
verfasst von
Valentina Bellemo
Gilbert Lim
Tyler Hyungtaek Rim
Gavin S. W. Tan
Carol Y. Cheung
SriniVas Sadda
Ming-guang He
Adnan Tufail
Mong Li Lee
Wynne Hsu
Daniel Shu Wei Ting
Publikationsdatum
01.09.2019
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 9/2019
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-019-1189-3

Weitere Artikel der Ausgabe 9/2019

Current Diabetes Reports 9/2019 Zur Ausgabe

Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors)

Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Liver to Pancreas Transdifferentiation

Commentary for Debate

Commentary/Introduction for “Debate on Insulin vs. Non-insulin Use in the Hospital Setting” Articles

Diabetes Epidemiology (E Selvin and K Foti, Section Editors)

Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond

Microvascular Complications—Retinopathy (DL Chao and G Yiu, Section Editors)

Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA

Debate

Debate on Insulin vs Non-insulin Use in the Hospital Setting—Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise